We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPGI
3326
GPGI Inc
GPGI
$3.7B
$16K ﹤0.01%
3,848
-4,088
-52% -$17K
CMT icon
3327
Core Molding Technologies
CMT
$224M
$16K ﹤0.01%
1,212
-256
-17% -$2.72K
COFS icon
3328
Choiceone Financial
COFS
$514M
$16K ﹤0.01%
566
-108
-16% -$2.53K
COMP icon
3329
Compass
COMP
$9.99B
$16K ﹤0.01%
6,704
-4,774
-42% -$12.5K
CRD.B icon
3330
Crawford & Co Class B
CRD.B
$593M
$16K ﹤0.01%
2,980
-1,825
-38% -$10.2K
CRS icon
3331
Carpenter Technology
CRS
$27.1B
$16K ﹤0.01%
436
-18,130
-98% -$691K
DALN
3332
DELISTED
DallasNews
DALN
$16K ﹤0.01%
4,019
+730
+22% +$3.33K
DBVT
3333
DBV Technologies
DBVT
$881M
$16K ﹤0.01%
1,031
+600
+139% +$8.82K
DEA
3334
Easterly Government Properties
DEA
$1.17B
$16K ﹤0.01%
452
-1,181
-72% -$45.9K
DGICA icon
3335
Donegal Group Class A
DGICA
$696M
$16K ﹤0.01%
1,136
-3,489
-75% -$50.7K
DOUG icon
3336
Douglas Elliman
DOUG
$185M
$16K ﹤0.01%
4,083
-590
-13% -$2.35K
ELVN icon
3337
Enliven Therapeutics
ELVN
$4.31B
$16K ﹤0.01%
+959
New +$15.3K
EQH icon
3338
Equitable Holdings
EQH
$14.5B
$16K ﹤0.01%
571
-639
-53% -$18.9K
ESRT icon
3339
Empire State Realty Trust
ESRT
$822M
$16K ﹤0.01%
2,322
-19,883
-90% -$140K
EWD icon
3340
iShares MSCI Sweden ETF
EWD
$587M
$16K ﹤0.01%
+482
New +$15.1K
EWW icon
3341
iShares MSCI Mexico ETF
EWW
$1.86B
$16K ﹤0.01%
316
+314
+15,700% +$15.8K
KYNB
3342
Kyntra Bio
KYNB
$28.5M
$16K ﹤0.01%
41
-519
-93% -$199K
FGNX
3343
FG Nexus Inc
FGNX
$40.8M
$16K ﹤0.01%
25
-12
-32% -$3.37K
FLIC
3344
DELISTED
First of Long Island Corp
FLIC
$16K ﹤0.01%
901
-3,361
-79% -$61K
FORM icon
3345
FormFactor
FORM
$10.3B
$16K ﹤0.01%
716
-11,054
-94% -$258K
FVD icon
3346
First Trust Value Line Dividend Fund
FVD
$8.41B
$16K ﹤0.01%
391
-49,566
-99% -$1.94M
GABC icon
3347
German American Bancorp
GABC
$1.93B
$16K ﹤0.01%
444
-2,664
-86% -$101K
HEI icon
3348
HEICO Corp
HEI
$52.4B
$16K ﹤0.01%
102
-848
-89% -$132K
HIVE
3349
HIVE Digital Technologies
HIVE
$736M
$16K ﹤0.01%
11,083
-3,989
-26% -$10.2K
HY icon
3350
Hyster-Yale Materials Handling
HY
$618M
$16K ﹤0.01%
656
-1,348
-67% -$37.5K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.